FIELD: biochemistry.
SUBSTANCE: method for purifying fibrinogen from a fibrinogen-containing source, a fibrinogen product for pharmaceutical use obtained by the above method (variants), and a means for purifying or producing the fibrinogen product. Method comprises pretreating a fibrinogen-containing source to form a fibrinogen-containing solution, precipitation of fibrinogen from the solution in the presence of one or more Ca2+chelating agents and removing the supernatant from the fibrinogen paste. Moreover, fibrinogen is extracted from the forming fibrinogen-containing liquid fraction and undissolved paste residue, where the insoluble residue separates from the liquid in the absence of a protease inhibitor. Means for purifying or producing a fibrinogen product is an anion exchange resin.
EFFECT: invention provides a concentrate of fibrinogen produced with the intended elimination of pathogens and/or inactivation steps in the preparation process.
30 cl, 2 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
METHOD OF OBTAINING FIBRINOGEN CONCENTRATE | 2013 |
|
RU2556804C2 |
METHOD FOR PRODUCING EX VIVO SOLUBLE FIBRINOGEN | 2014 |
|
RU2571288C1 |
METHOD OF PURIFYING THERAPEUTIC PROTEINS | 2013 |
|
RU2685956C2 |
METHOD OF EXTRACTING PLASMINOGEN OR PLASMIN FROM MIXTURE IN PRESENCE OF FIBRINOGEN | 2002 |
|
RU2458067C2 |
PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
REAGENT FOR EVALUATING CROSS-CROSSLINKED FIBRIN SPLITTING PRODUCT AND METHOD OF SUCH EVALUATION | 2017 |
|
RU2742279C2 |
METHOD FOR SEPARATION OF BLOOD PROTEINS | 0 |
|
SU1837880A3 |
METHOD OF PROVIDING IMPROVED SEALING BY MEANS OF FIBRIN | 2011 |
|
RU2556960C2 |
FUSION PROTEIN PURIFICATION METHOD | 2015 |
|
RU2698654C2 |
Authors
Dates
2018-08-09—Published
2013-03-12—Filed